Discover trends, market shifts, and competitive outlooks for the montelukast sodium industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What is the Projected CAGR for the Montelukast Sodium Market Size from 2025 to 2034?

In recent times, the montelukast sodium market has seen substantial growth. It is projected to expand from a size of $3.86 billion in 2024, to a much larger $4.24 billion in 2025, indicating a compound annual growth rate (CAGR) of 9.9%. Factors that have fueled this growth in the historic period include the rise in respiratory diseases, an increase in the aging population, the elevation of air pollution, enhanced awareness and education about the drug, and the growth of emerging markets.

The market size of montelukast sodium is expected to witness substantial growth in the coming years, inflating to a worth of $6.12 billion in 2029 with a compound annual growth rate (CAGR) of 9.6%. The surge during the forecast period can be credited to factors such as regulatory approvals and product launches, clinical research, patent expirations, regulatory modifications, and doctor prescribing behaviours. Some major trends projected during the forecast period encompass heightened competition from generic drugs, a move towards combination treatments, growth in emerging markets, emphasis on use in children, and adoption of digital health technologies.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16123&type=smp

What External and Internal Drivers Are Contributing to the Growth of the Montelukast Sodium Market?

The escalating incidences of asthma are slated to boost the advancement of the montelukast sodium market. Characterized by inflammation and constriction of airways, asthma is a long-term respiratory disorder which triggers frequent episodes of wheezing, breathlessness, tightness in the chest, and coughing bouts. The augmenting cases of asthma can be attributed to factors like environmental pollution, exposure to allergens, genetic factors, urbanization, alterations in lifestyle, and respiratory infections. Montelukast sodium is utilized in asthma treatment since it acts as a leukotriene receptor adversary, thereby aiding in the prevention and management of asthma symptoms by obstructing the action of leukotrienes responsible for airway inflammation and constriction. For instance, data from the American Lung Association, a voluntary health establishment based in the US, pointed out that in 2022, around 44.2 million Americans or 13.5% of the populace had been diagnosed with asthma by medical professionals. Consequently, the rising occurrences of asthma are fueling the expansion of the montelukast sodium market.

Which Key Market Segments Comprise the Montelukast Sodium Market and Drive Its Revenue Growth?

The montelukast sodium market covered in this report is segmented –

1) By Product: Crystal-like, Form-less Or Amorphous

2) By Dosage Form: Tablets, Oral Solutions

3) By Application: Bronchospasm, Allergic Coryza, Asthma, Urticaria, Other Applications

Subsegments:

1) By Crystal-Like: Monohydrate Crystal, Anhydrous Crystal, Spherical Crystals, Needle-Like Crystals, Polycrystalline Montelukast Sodium

2) By Form-Less Or Amorphous: Amorphous Powder, Amorphous Granules, Non-Crystalline Montelukast Sodium

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=16123&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Montelukast Sodium Market?

North America was the largest region in the montelukast sodium market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the montelukast sodium market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Cutting-Edge Market Trends Are Expected to Drive the Montelukast Sodium Market’s Growth?

To offer more suitable treatments for individuals managing asthma and allergic rhinitis, key players in the montelukast sodium market are introducing new drugs, including over-the-counter generic medication. Over-the-counter (OTC) generic treatments are drugs accessible without a prescription, typically located in pharmacies or retail outlets. For example, in July 2022, Fexofenadine HCL 180 mg and Pseudoephedrine HCl 240 mg were launched in the US by Dr. Reddy’s Laboratories, a pharmaceutical company based in India. This medication is intended for temporary relief from colds or allergies-induced nasal and sinus congestion. It is equivalent to Allegra-D 24 HR and combines an antihistamine with a nasal decongestant to relieve symptoms like sneezing, runny nose, itchy eyes, and throat. It comes in 5, 10, and 15-count pack sizes and provides a high-quality, cost-effective solution for those looking for relief from upper respiratory discomfort.

View the full report here:

https://www.thebusinessresearchcompany.com/report/montelukast-sodium-global-market-report

How Is the Montelukast Sodium Market Conceptually Defined?

Montelukast sodium is a leukotriene receptor antagonist, meaning it works by blocking the action of leukotrienes that cause asthma symptoms and allergic reactions. It is used to manage and prevent symptoms of asthma and to relieve seasonal and perennial allergic rhinitis. Montelukast is typically administered orally in tablet form.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16123

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model